Blossom Mak

5PUBLICATIONS
19CO-AUTHORS
Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 25, 2023
Multi-Omic Integration of Blood-Based Tumor-Associated Genomic and Lipidomic Profiles Using Machine Learning Models in Metastatic Prostate Cancer.

Shikai Fang, Shandian Zhe, Hui-Ming Lin

|May 05, 2023
PCPro: a clinically accessible, circulating lipid biomarker signature for poor-prognosis metastatic prostate cancer.

Tahlia Scheinberg, Hui-Ming Lin, Michael Fitzpatrick

|Feb 06, 2023
Targeting lipid metabolism in metastatic prostate cancer.

Tahlia Scheinberg, Blossom Mak, Lisa Butler

|Oct 14, 2022
Modulation of Plasma Lipidomic Profiles in Metastatic Castration-Resistant Prostate Cancer by Simvastatin.

Blossom Mak, Hui-Ming Lin, Thy Duong

|Apr 25, 2022
GUIDE: a randomised non-comparative phase II trial of biomarker-driven intermittent docetaxel versus standard-of-care docetaxel in metastatic castration-resistant prostate cancer (clinical trial protocol).

Ciara Conduit, Blossom Mak, Wenjia Qu

Pageof 1

Frequent Collaborators

3 joint publications

Hui-Ming Lin

3 joint publications

Tahlia Scheinberg

2 joint publications

Peter J Meikle

2 joint publications

Arun A Azad